image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates

Microlise

May 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SAAS
  • Price:
  • 166.5p
Microlise’s FY23 results showed 14% growth in sales to £72m and also point to an acceleration of performance in H2 vs H1 (10.5% growth rising to 16.3%). EBITDA increased 15% to £9.4m. Microlise extended 40 contracts with existing large enterprise customers (e.g. Sainsbury’s, Sports Direct) and saw 40 renewals in the period (e.g. Tesco), and the mission critical nature of its operations saw customer churn remain low at 0.7%. The year also experienced record sales into OEMs and a strong pitch-to-win rate for direct sales with 450+ new customers added. The number of subscriptions grew by 7% to 640k, which helped drive recurring revenues by 11% to £45m - to represent 63% of sales. Hardware was +19% to £23.7m and Services +10% to £3m.< ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Mircrolise (September 2024)
Microlise - ARR up 11% to £47.2m (February 2024)
Microlise - Interesting new issue (September 2021)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW